Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
A 66-year-old male received an implant of a dual-chamber implantable cardioverter-defibrillator (ICD) and was prescribed amiodarone (400 mg/day). The intra-thoracic impedance monitor in the ICD antecedently detected amiodarone-induced acute fibrosing alveolitis >3 months prior to clinical symptoms.
Hsieh
Yu-Cheng
YC
Cardiovascular Center, Taichung Veterans General Hospital, 160, Section 3, Chung-Kang Road, Taichung 407, Taiwan.
Huang
Jin-Long
JL
Chin
Chun-Shih
CS
Lin
Tung-Chao
TC
Liao
Ying-Chieh
YC
Ting
Chih-Tai
CT
Wu
Tsu-Juey
TJ
D000208:Acute Disease; D000368:Aged; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000628:therapy*; D017147:Defibrillators, Implantable; D003937:Diagnosis, Differential; D004417:Dyspnea / Q000175:diagnosis / Q000209:etiology; D006333:Heart Failure / Q000175:diagnosis; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis*
D000889:Anti-Arrhythmia Agents; D011239:Prednisolone; D000638:Amiodarone